Výsledky vyhledávání - "R, Sambugaro"

Akademický článek

Inflammation in Respiratory Allergy Treated by Sublingual Immunotherapy

Autor: F. Frati, S. Scurati, P. Puccinelli, C. Morviducci, G. Di Cara, R. Boccardo, E. Piergentili, M. Milioni, R. Bernardini, R. Sambugaro, F. Castellano, A. Varricchio, G. Manfredi, L. Cordero, M. Russello, E. Guercio, M. Mauro, C. Incorvaia

Publikováno v: European Journal of Inflammation, Vol 7 (2009)

The most common allergic diseases, such as rhinitis, asthma and atopic dermatitis, are sustained by allergic inflammation, the treatment of which requires anti-inflammatory activity. Among the available treatments, allergen immunotherapy (IT) has a d

Externí odkaz: https://doaj.org/article/c3054388993845549fffeb0cdbe2f7e5

Zobrazit plný text záznamu

Akademický článek

Intermittent and Persistent Allergic Rhinitis and Association with Asthma in Children

Publikováno v: European Journal of Inflammation, Vol 6 (2008)

The natural history of allergic rhinitis (AR) is commonly characterized by worsening of symptom severity, frequent comorbidity with asthma, and polysensitization to aeroallergens. The polysensitization phenomenon starts in early childhood. AR classif

Externí odkaz: https://doaj.org/article/2c5aabfb34e04ea4bf01b2d0ec371e97

Zobrazit plný text záznamu

Applicability of extracellular electrical impedance tomography in monitoring respiratory tract inflammation

Autor: V, Di Rienzo, M, Minelli, R, Sambugaro, F, Agostinis, E, Nucera, D, Schiavino, G, Patriarca

Publikováno v: Journal of investigational allergologyclinical immunology. 17(1)

The presence of persistent mild inflammation is widely considered to provide the immunopathogenic basis for bronchial, nasal, or sinusal inflammation between critical phases and in asymptomatic periods. Exhaled nitric oxide (NO) is currently the most

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7ee1784a87a0633848b9f61ae8ac2f5d
https://pubmed.ncbi.nlm.nih.gov/17323861

Zobrazit plný text záznamu

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

Autor: A. Musarra, Walter Canonica, V. Di Rienzo, R. Sambugaro, Giovanni Passalacqua, M. Minelli, S. Pecora

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 35(5)

Summary Background The age below 5 years is considered a prudential limit for immunotherapy in view of the possible severity of side-effects. Sublingual immunotherapy (SLIT) seems to be safe, but no study in very young children is available. We perfo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a7e92ce03c0e4b680086baf755a9cd
https://pubmed.ncbi.nlm.nih.gov/15898975

Zobrazit plný text záznamu

The efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase

Autor: Samuele E. Burastero, Paola Puccinelli, R. Sambugaro, V. Di Rienzo

Publikováno v: Allergologia et immunopathologia. 31(6)

Sublingual administration of allergens is a safe and effective alternative to subcutaneous immunotherapy in patients with respiratory allergies. A drawback to this therapeutic approach is the relatively long and complex management of the induction ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::371cd8ebd2d4c5af8ffb1206685ab6f8
https://pubmed.ncbi.nlm.nih.gov/14670288

Zobrazit plný text záznamu